Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for NewGenIvf (NIVF) over the last 3 years, with Q4 2024 value amounting to $743323.0.

  • NewGenIvf's Shares Outstanding (Diluted Average) rose 231676.04% to $743323.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $743323.0, marking a year-over-year increase of 231676.04%. This contributed to the annual value of $743323.0 for FY2024, which is 231676.04% up from last year.
  • Latest data reveals that NewGenIvf reported Shares Outstanding (Diluted Average) of $743323.0 as of Q4 2024, which was up 231676.04% from $30757.0 recorded in Q4 2023.
  • NewGenIvf's Shares Outstanding (Diluted Average)'s 5-year high stood at $743323.0 during Q4 2024, with a 5-year trough of $28797.0 in Q4 2022.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $267625.7, with a median of $30757.0 in 2023.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 680.63% in 2023, then surged by 231676.04% in 2024.
  • Quarter analysis of 3 years shows NewGenIvf's Shares Outstanding (Diluted Average) stood at $28797.0 in 2022, then grew by 6.81% to $30757.0 in 2023, then surged by 2316.76% to $743323.0 in 2024.
  • Its Shares Outstanding (Diluted Average) was $743323.0 in Q4 2024, compared to $30757.0 in Q4 2023 and $28797.0 in Q4 2022.